SCHEMBL24519035

SCHEMBL24519035

c1ccc2cc3c(cc2c1)sc1ccc2oc4ccc(-c5c6ccccc6c(-c6ccc7oc8ccccc8c7c6)c6ccccc56)cc4c2c13

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.36
MAPT P10636 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
RAB9A P51151 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.34
AHR P35869 2/20 0.33
CHEK2 O96017 1/20 0.32
CASP3 P42574 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17247074 0.90 MAPT (0.40) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL24519034 0.89 NPC1 (0.37) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL22217597 0.89 MAPT (0.39) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL22253791 0.88 MAPT (0.38) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL24519055 0.87 MAPT (0.40) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL19080400 0.87 CASP3 (0.33) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL17247118 0.86 MAPT (0.39) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL17945341 0.86 MAPT (0.41) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL19080397 0.85 NPC1 (0.34) NPC1MAPTKDM4EMEN1ALDH1A1
SCHEMBL24518919 0.84 KDM4E (0.35) NPC1MAPTKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2022-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same CCNL2, CRY1, CYP2S1 NPC1 3379/4885MAPT 4193/4885KDM4E 3061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.